Esther Tanzman
Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Survivors | 1 | 2010 | 45 |
Why?
|
Student Health Services | 3 | 1992 | 5 |
Why?
|
HIV Infections | 3 | 2001 | 136 |
Why?
|
Breast Neoplasms | 1 | 2010 | 185 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2001 | 10 |
Why?
|
Students, Health Occupations | 1 | 2001 | 1 |
Why?
|
Blood-Borne Pathogens | 1 | 2001 | 2 |
Why?
|
Developing Countries | 1 | 2001 | 28 |
Why?
|
Hepatitis B | 1 | 2001 | 18 |
Why?
|
Health Personnel | 1 | 2001 | 54 |
Why?
|
Academic Medical Centers | 1 | 2001 | 65 |
Why?
|
Universities | 2 | 1992 | 28 |
Why?
|
Societies, Medical | 2 | 2001 | 90 |
Why?
|
Anti-HIV Agents | 2 | 2001 | 44 |
Why?
|
Rape | 1 | 1992 | 4 |
Why?
|
Students | 1 | 1992 | 38 |
Why?
|
Fund Raising | 1 | 2010 | 3 |
Why?
|
Physicians, Women | 1 | 2010 | 8 |
Why?
|
United States | 2 | 2001 | 604 |
Why?
|
Social Support | 1 | 2010 | 111 |
Why?
|
Tetracycline | 1 | 1988 | 20 |
Why?
|
Acne Vulgaris | 1 | 1988 | 10 |
Why?
|
Phosphonic Acids | 1 | 2007 | 9 |
Why?
|
Occupational Health Services | 1 | 2007 | 11 |
Why?
|
Chemoprevention | 1 | 2007 | 12 |
Why?
|
Lamivudine | 1 | 2007 | 18 |
Why?
|
Adenine | 1 | 2007 | 26 |
Why?
|
Zidovudine | 1 | 2007 | 23 |
Why?
|
Occupational Exposure | 1 | 2007 | 53 |
Why?
|
Humans | 7 | 1988 | 1856 |
Why?
|
Needlestick Injuries | 1 | 2001 | 3 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2001 | 4 |
Why?
|
Australia | 1 | 2001 | 27 |
Why?
|
Risk Management | 1 | 2001 | 15 |
Why?
|
Centers for Disease Control and Prevention (U.S.) | 1 | 2001 | 20 |
Why?
|
Canada | 1 | 2001 | 60 |
Why?
|
Great Britain | 1 | 2001 | 49 |
Why?
|
Ethics, Medical | 1 | 2001 | 39 |
Why?
|
Hepatitis B Vaccines | 1 | 1999 | 17 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1999 | 53 |
Why?
|
Adjuvants, Immunologic | 1 | 1999 | 73 |
Why?
|
Female | 4 | 1992 | 1643 |
Why?
|
Vaccination | 1 | 1999 | 92 |
Why?
|
New York | 2 | 1992 | 422 |
Why?
|
Retrospective Studies | 2 | 1992 | 653 |
Why?
|
Violence | 1 | 1992 | 31 |
Why?
|
Sexual Behavior | 1 | 1992 | 37 |
Why?
|
Prevalence | 1 | 1992 | 281 |
Why?
|
Adult | 3 | 1992 | 1317 |
Why?
|
Long-Term Care | 1 | 1988 | 38 |
Why?
|
Public Health Administration | 1 | 2007 | 14 |
Why?
|
Adolescent | 2 | 1992 | 891 |
Why?
|
Drug Combinations | 1 | 2007 | 95 |
Why?
|
Patient Compliance | 1 | 2007 | 113 |
Why?
|
Middle Aged | 2 | 1992 | 1161 |
Why?
|
Sex Factors | 1 | 2007 | 284 |
Why?
|
Logistic Models | 1 | 2007 | 251 |
Why?
|
Hepatitis B Surface Antigens | 1 | 1999 | 7 |
Why?
|
Hepatitis B Antibodies | 1 | 1999 | 11 |
Why?
|
Risk Factors | 1 | 2007 | 555 |
Why?
|
Double-Blind Method | 1 | 1999 | 274 |
Why?
|
Recombinant Proteins | 1 | 1999 | 290 |
Why?
|
Male | 2 | 1999 | 1553 |
Why?
|
